June 26, 2025AstraZeneca's New Phase I Study on AZD5492: What Investors Need to Know ~1 min.AstraZeneca PLC has recently announced positive results from a Phase I study on its new drug candidate, AZD5492....
March 20, 2025AstraZeneca AZN: Among the Best Diabetes Stocks to Buy According to Billionaires ~1 min.AstraZeneca PLC (AZN) has been recognized as one of the best diabetes stocks to buy by billionaires....
March 16, 2025AstraZeneca's Experimental Blood Pressure Drug Could Become a Blockbuster ~2 min.AstraZeneca PLC (NASDAQ:AZN) has recently developed an experimental drug for treating high blood pressure, which experts believe has a strong potential to become a blockbuster in the pharmaceutical market....
March 15, 2025AstraZeneca's Experimental Blood Pressure Drug Shows Promising Results, Outperforms Broader Market ~1 min.AstraZeneca PLC's recent experimental blood pressure drug has shown promising results, performing significantly better than the broader market....
March 14, 2025AstraZeneca's Imfinzi success a step towards revolutionizing cancer treatment ~2 min.AstraZeneca PLC (AZN) continues to make significant strides in the field of cancer treatment with its groundbreaking drug, Imfinzi....
March 5, 2025ASTRAZENECA PLC Stock Hits Price Target Forecast with 13.63% Profit ~1 min.On January 28, 2025, QuantWave issued a long signal for ASTRAZENECA PLC stock when it was trading at 68.61 $....
March 4, 2025ASTRAZENECA PLC Hits Price Target Forecast with 13.62% Profit: A Sign of QuantWave's Accuracy ~2 min.ASTRAZENECA PLC (AZN) recently reached the price target forecast set by QuantWave on March 4, 2025, resulting in a profit of 13.62% for investors who followed the long signal issued on February 4, 2025....
February 28, 2025AstraZeneca PLC AZN: A Global Pharmaceutical Giant with Promising Growth Potential ~2 min.AstraZeneca PLC (AZN) is a renowned multinational pharmaceutical company with a strong presence in the global market....
February 26, 2025AstraZeneca PLC's Groundbreaking Research Leads to Exciting Discoveries in the Field of Medicine ~2 min.AstraZeneca PLC, a leading pharmaceutical company, has made significant advancements in the field of medicine through its groundbreaking research....
February 24, 2025AstraZeneca PLC Announces Positive Results from Clinical Trial ~2 min.AstraZeneca PLC, a leading pharmaceutical company, announced today that its latest clinical trial for a new drug has yielded positive results....
August 2, 2024ASTRAZENECA PLC Hits Price Target Forecast with 26.05% Profit, Confirms QuantWave Accuracy ~2 min.QuantWave's forecast for ASTRAZENECA PLC proved to be highly accurate as the stock reached the predicted price target on August 2, 2024....
February 14, 2025AstraZeneca PLC AZN Q4 2024 Earnings Call Highlights: Strong Revenue Growth Amidst Challenges ~2 min.During the recent Q4 2024 earnings call, AstraZeneca PLC (AZN) reported impressive financial results amidst various challenges faced by the pharmaceutical company....
April 25, 2024ASTRAZENECA PLC Stock Hits QuantWave Price Target Forecast with 11.99% Profit ~2 min.ASTRAZENECA PLC stock recently reached the price target forecast set by QuantWave, with a profitable outcome of 11.99%. The forecast signal was issued on April 2, 2024, with the stock priced at 65.65 $....
February 7, 2025AstraZeneca Plc Reports Strong Q4 2024 Earnings, Impressive Growth Prospects in the Pipeline ~2 min.AstraZeneca Plc, a renowned multinational pharmaceutical company, recently released its impressive Q4 2024 earnings report, showcasing remarkable growth prospects in its pipeline....
October 31, 2024AstraZeneca PLC Collaborates with Monopar Therapeutics on Rare Disease Treatment ~1 min.Monopar Therapeutics, a biopharmaceutical company specializing in rare disease treatments, has announced a groundbreaking partnership with AstraZeneca PLC....
